Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
bifasisk insulin aspart 30/70 100 enheder/ml injektionsvæske i fyldt pen a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fondaparinuxnatrium 2,5 mg i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Zinksulfat 500 mikromol/10 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
anakinra 100 mg/0,67 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
parecoxib 40 mg injektion (pulver til rekonstitution) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
parecoxib 40 mg injektion (pulver til rekonstitution) + diluent |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ibandronsyre 1 mg/ml koncentrat til intravenøs infusion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 60 mg/3 ml intraartikulær injektionsvæske, i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2a 180 µg/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2a 135 µg/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely temoporfin 4 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
caspofungin 50 mg pulver til injektionsvæske, koncentrat til rekonstitution |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
levende attenueret vaccine injektionsvæske mod varicella zoster (pulver til rekonstitution) + solvent |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Interferon alfa-containing product |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Interferon beta-containing product |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing interferon gamma (medicinal product) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 0,1 % infusionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 0,125 % infusionsvæske, opløsning, pose a 250 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 150 mg(I)/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 240 mg(I)/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 300 mg(I)/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 370 mg(I)/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
megluminiothalamat 60 % injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iomeprol 150 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iomeprol 250 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gadobutrol 1 mmol/ml injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gadobutrol 1 mmol/ml injektionsvæske, opløsning i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iomeprol 300 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Porfimer sodium 15 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
testosteronestere 100 mg olieholdig injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + adrenalin 0,5 %/50 µg/10 ml (1:200.000) injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
testosteronestere 250 mg olieholdig injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dolasetronmesilat 20 mg/ml injektionsvæske, opløsning, hætteglas a 0,625 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dolasetronmesilat 20 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
oxycodonhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
oxycodonhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
colistimethatnatrium 2 million enheder til pulver til injektionsvæske, rekonstitution |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
enfuvirtid 90 mg/ml pulver til injektionsvæske, rekonstitution + opløsningsmiddel |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dobutamin 12,5 mg/ml koncentrat til infusionsvæske til intravenøs anvendelse, ampul a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
basiliximab 10 mg injektionsvæske (pulver til rekonstitution) + solvens |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + fentanyl 0,1%/2µg/mL injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 1500 IEi fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant normalt immunglobulin 500 mg pulver tilinfusionsvæske, rekonstitution + solvens, til intravenøs anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant normalt immunglobulin 2,5 g pulver til injektionsvæske, rekonstitution + solvens til intravenøs anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant normalt immunglobulin 5 g pulver til infusionsvæske, rekonstitution + solvens, til intravenøs anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant normalt immunglobulin 10 g infusionsvæske, pulver + solvent til rekonstitution, til intravenøs anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
pegfilgrastim 6 mg/0,6 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
adalimumab 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
teriparatid 250 µg/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 450 IE pulver til injektionsvæske, rekonstitution + solvens |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 1050 IE pulver til injektionsvæske, rekonstitution + solvens |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ketorolactrometamol 15 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 2 mg/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 4 mg/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 5 mg/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 8 mg/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 25mg/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 50 mg/ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
pethidinhydrochlorid 25 mg/1 ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
pethidinhydrochlorid 75 mg/1 ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
thiopentalnatrium 20 mg/ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + adrenalin 0,75 %/1:200.000 injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1,5 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:500.000 injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mepivacainhydrochlorid 3 %/levonordefrin 1:20.000 injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
prilocainhydrochlorid 4 %/adrenalin 200.000 injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ropivacainhydrochlorid 5 mg/ml injektionsvæske, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,2 %/glucose 6% injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,3 %/glucose 6 % injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
propoxycainhydrochlorid 7,2 mg + procainhydrochlorid 36 mg + adrenalin 0,12 mg dentaltype, cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kanamycinsulfat 75 mg/2 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kanamycinsulfat 500 mg/2 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tobramycin 10 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tobramycin 1,2 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bacitracin 50.000 enheder, pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
imipenem 750 mg + cilastatin 750 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cefapirinnatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cefazolin 250 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cefradin 250 mg pulver til injektionsvæske, rekonstitution |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cefmetazolnatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cefmetazolnatrium 2 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cefmetazolnatrium 20 mg/ml injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cefmetazolnatrium 40 mg/ml pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ceftizoximnatrium 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ceftizoximnatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ticarcillin 3 g + clavulansyre 100 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Ampicillin (as ampicillin sodium) 125 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|